Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GRANDIOSA - Growth, Allergy and Neurodevelopment in Infants on Hydrolysed Formula

NCT05578716 is registered in ClinicalTrials.gov with Umeå University as lead sponsor.

NCT NCT05578716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05578716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GRANDIOSA - Growth, Allergy and Neurodevelopment in Infants on Hydrolysed Formula
Lead sponsor
Umeå University
Phase
Not applicable
Overall status
Unknown status
Start date
October 3, 2022
Completion date
June 30, 2026
Enrollment
312 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

infant formula